Miller SD - Search Results

1

Sephin1, which prolongs the integrated stress response, is a promising therapeutic for multiple sclerosis.

Chen Y, Podojil JR, Kunjamma RB, Jones J, Weiner M, Lin W, Miller SD, Popko B. Chen Y, et al. Among authors: miller sd. Brain. 2019 Feb 1;142(2):344-361. doi: 10.1093/brain/awy322. Brain. 2019. PMID: 30657878 Free PMC article.

2

Two models of multiple sclerosis: experimental allergic encephalomyelitis (EAE) and Theiler's murine encephalomyelitis virus (TMEV) infection. A pathological and immunological comparison.

Dal Canto MC, Melvold RW, Kim BS, Miller SD. Dal Canto MC, et al. Among authors: miller sd. Microsc Res Tech. 1995 Oct 15;32(3):215-29. doi: 10.1002/jemt.1070320305. Microsc Res Tech. 1995. PMID: 8527856 Free PMC article. Review.

3

Differential expression of inflammatory cytokines parallels progression of central nervous system pathology in two clinically distinct models of multiple sclerosis.

Begolka WS, Vanderlugt CL, Rahbe SM, Miller SD. Begolka WS, et al. Among authors: miller sd. J Immunol. 1998 Oct 15;161(8):4437-46. J Immunol. 1998. PMID: 9780223

4

Mechanisms of immunotherapeutic intervention by anti-CD40L (CD154) antibody in an animal model of multiple sclerosis.

Howard LM, Miga AJ, Vanderlugt CL, Dal Canto MC, Laman JD, Noelle RJ, Miller SD. Howard LM, et al. Among authors: miller sd. J Clin Invest. 1999 Jan;103(2):281-90. doi: 10.1172/JCI5388. J Clin Invest. 1999. PMID: 9916140 Free PMC article.

5

Mouse models of multiple sclerosis: experimental autoimmune encephalomyelitis and Theiler's virus-induced demyelinating disease.

Fuller KG, Olson JK, Howard LM, Croxford JL, Miller SD. Fuller KG, et al. Among authors: miller sd. Methods Mol Med. 2004;102:339-61. doi: 10.1385/1-59259-805-6:339. Methods Mol Med. 2004. PMID: 15286394

6

Towards cannabis and cannabinoid treatment of multiple sclerosis.

Croxford JL, Miller SD. Croxford JL, et al. Among authors: miller sd. Drugs Today (Barc). 2004 Aug;40(8):663-76. doi: 10.1358/dot.2004.40.8.850469. Drugs Today (Barc). 2004. PMID: 15510238 Review.

7

Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis.

McMahon EJ, Bailey SL, Castenada CV, Waldner H, Miller SD. McMahon EJ, et al. Among authors: miller sd. Nat Med. 2005 Mar;11(3):335-9. doi: 10.1038/nm1202. Epub 2005 Feb 27. Nat Med. 2005. PMID: 15735651

8

CD28 regulates glucocorticoid-induced TNF receptor family-related gene expression on CD4+ T cells via IL-2-dependent mechanisms.

Kohm AP, Podojil JR, Williams JS, McMahon JS, Miller SD. Kohm AP, et al. Among authors: miller sd. Cell Immunol. 2005 May;235(1):56-64. doi: 10.1016/j.cellimm.2005.07.002. Epub 2005 Aug 30. Cell Immunol. 2005. PMID: 16137665

9

Cutting Edge: Anti-CD25 monoclonal antibody injection results in the functional inactivation, not depletion, of CD4+CD25+ T regulatory cells.

Kohm AP, McMahon JS, Podojil JR, Begolka WS, DeGutes M, Kasprowicz DJ, Ziegler SF, Miller SD. Kohm AP, et al. Among authors: miller sd. J Immunol. 2006 Mar 15;176(6):3301-5. doi: 10.4049/jimmunol.176.6.3301. J Immunol. 2006. PMID: 16517695

10

CD4+ T cell expressed CD80 regulates central nervous system effector function and survival during experimental autoimmune encephalomyelitis.

Podojil JR, Kohm AP, Miller SD. Podojil JR, et al. Among authors: miller sd. J Immunol. 2006 Sep 1;177(5):2948-58. doi: 10.4049/jimmunol.177.5.2948. J Immunol. 2006. PMID: 16920930

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

683 results

Search Page

Filters